Pfizer Inc.

NYSE: PFE · Real-Time Price · USD
25.11
0.00 (0.00%)
At close: Aug 15, 2025, 12:30 PM

Pfizer Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 29, 2025 Mar 29, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021
Revenue
63.83B 62.46B 63.63B 60.43B 56.22B 55.95B 59.55B 69.27B 78.42B 93.16B 100.33B 99.88B 101.28B 92.43B 81.29B 69.08B 55.33B 46.29B
Cost of Revenue
20.85B 20.65B 21.15B 24.94B 28.61B 28.17B 29.74B 32.05B 28.43B 32.91B 37.75B 37.53B 41.4B 40.18B 34.38B 27.39B 19.39B 14.23B
Gross Profit
42.99B 41.81B 42.48B 35.49B 27.61B 27.78B 29.82B 37.23B 49.99B 60.25B 62.58B 62.35B 59.88B 52.26B 46.91B 41.7B 35.94B 32.06B
Operating Income
18.89B 17.2B 17.13B 10.14B 2.17B 2.64B 4.77B 11.38B 24.08B 34.68B 38.04B 35.97B 34.02B 27.06B 21.83B 19.47B 14.22B 10.74B
Interest Income
585M 559M 545M 984M 1.39B 1.58B 1.63B 1.15B 700M 414M 251M 128M 68M 51M 37M 27M 32M 38M
Pretax Income
10.53B 7.39B 8.02B 3.9B -4.16B -1.79B 1.06B 10.42B 22.77B 31.95B 34.73B 33.33B 32.17B 27.67B 24.31B 21.04B 13.77B 9.84B
Net Income
10.73B 7.87B 8.02B 4.27B -2.59B -288M 2.13B 10.47B 21.49B 29.04B 31.37B 29.77B 29.3B 25.22B 22.23B 19.68B 12.99B 10.68B
Selling & General & Admin
13.89B 14.18B 14.61B 14.86B 14.83B 14.57B 14.47B 14.43B 14.47B 13.95B 13.11B 12.65B 12.15B 12.06B 12.25B 11.96B 11.83B 11.6B
Research & Development
10.2B 10.44B 10.74B 10.49B 10.61B 10.56B 10.58B 11.42B 11.43B 11.62B 11.43B 13.73B 13.71B 13.14B 12.83B 10.27B 9.88B 9.72B
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
24.09B 24.61B 25.35B 25.35B 25.44B 25.14B 25.05B 25.85B 25.9B 25.57B 24.54B 26.38B 25.86B 25.2B 25.08B 22.23B 21.72B 21.32B
Interest Expense
2.83B 2.95B 3.09B 3.04B 2.95B 2.68B 2.21B 1.83B 1.45B 1.24B 1.24B 1.24B 1.25B 1.28B 1.29B 1.32B 1.34B 1.4B
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
44.94B 45.27B 46.5B 50.29B 54.05B 53.31B 54.79B 57.9B 54.34B 58.48B 62.29B 63.91B 67.26B 65.37B 59.46B 49.61B 41.11B 35.55B
Income Tax Expense
-235M -510M -28M -401M -1.6B -1.54B -1.11B -90M 1.23B 2.87B 3.33B 3.35B 2.66B 2.22B 1.85B 1.52B 1.5B 803M
Shares Outstanding (Basic)
5.68B 5.67B 5.67B 5.67B 5.67B 5.66B 5.65B 5.65B 5.65B 5.63B 5.62B 5.61B 5.59B 5.62B 5.62B 5.61B 5.6B 5.58B
Shares Outstanding (Diluted)
5.71B 5.71B 5.7B 5.71B 5.7B 5.7B 5.65B 5.65B 5.71B 5.73B 5.74B 5.72B 5.71B 5.76B 5.77B 5.72B 5.68B 5.66B
EPS (Basic)
1.89 1.39 1.42 0.75 -0.46 -0.06 0.38 1.86 3.82 5.18 5.59 5.31 5.23 4.50 3.97 3.52 2.33 1.92
EPS (Diluted)
1.88 1.38 1.41 0.74 -0.47 -0.07 0.35 1.82 3.75 5.07 5.47 5.19 5.11 4.40 3.90 3.46 2.29 1.89
EBITDA
22.77B 19.86B 20.75B 13.84B 5.49B 7.43B 9.56B 18.39B 29.99B 38.55B 41.03B 39.39B 38.4B 34.06B 30.73B 27.32B 19.94B 15.96B
EBIT
15.99B 12.96B 13.74B 6.94B -1.21B 893M 3.27B 12.26B 24.22B 33.19B 35.97B 34.56B 33.42B 28.95B 25.6B 22.36B 15.11B 11.24B
Depreciation & Amortization
6.79B 6.89B 7.01B 6.89B 6.7B 6.54B 6.29B 6.14B 5.76B 5.36B 5.06B 4.82B 4.98B 5.11B 5.13B 4.96B 4.83B 4.72B